ALS risk but not phenotype is affected by ataxin-2 intermediate length polyglutamine expansion

Neurology. 2011 Jun 7;76(23):2030-1. doi: 10.1212/WNL.0b013e31821e557a.
No abstract available

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Amyotrophic Lateral Sclerosis / epidemiology*
  • Amyotrophic Lateral Sclerosis / genetics*
  • Ataxins
  • Cohort Studies
  • DNA Repeat Expansion / genetics*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Nerve Tissue Proteins / chemistry
  • Nerve Tissue Proteins / deficiency
  • Nerve Tissue Proteins / genetics*
  • Peptides / genetics*
  • Phenotype
  • Risk Factors
  • Young Adult

Substances

  • Ataxins
  • Nerve Tissue Proteins
  • Peptides
  • polyglutamine